This document discloses molecules having the following formula (Formula One): ##STR00001##
and processes associated therewith.

A catheter assembly includes an elongated catheter shaft, a magnetic sensor, and one or more wires. The elongated catheter shaft has a shaft proximal end and a shaft distal end, and the magnetic sensor includes a coil having a coil proximal end and a coil distal end that is situated toward or at the shaft distal end. The one or more wires extend through the elongated catheter shaft and are situated adjacent the magnetic sensor. Each of the one or more wires is electrically coupled to the coil at the coil distal end.

This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions containing such molecules, and processes of using such pesticidal compositions against such pests. These pesticidal compositions may be used, for example, as acaricides, insecticides, miticides, molluscicides, and nematicides. This document discloses molecules having the following formula (Formula One).

##STR00001##

This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions containing such molecules, and processes of using such pesticidal compositions against such pests. These pesticidal compositions may be used, for example, as acaricides, insecticides, miticides, molluscicides, and nematicides. This document discloses molecules having the following formula (Formula One).

##STR00001##

In an embodiment, the present disclosure pertains to a solvent including a hydrocarbon oligomer with at least 20 carbon atoms, where the hydrocarbon oligomer has at least one of a low viscosity, a low vapor pressure, and a high flashpoint. In another embodiment, the present disclosure pertains to a solution including a poly (-olefin) and a reactive organometallic reagent. In a further embodiment, the present disclosure pertains to a solution including an oligomeric hydrocarbon and a reactive organometallic reagent. In an additional embodiment, the present disclosure pertains to a method for creating a solution, where the method includes adding a reactive organometallic reagent to an oligomeric hydrocarbon.

In an embodiment, the present disclosure pertains to a solvent including a hydrocarbon oligomer with at least 20 carbon atoms, where the hydrocarbon oligomer has at least one of a low viscosity, a low vapor pressure, and a high flashpoint. In another embodiment, the present disclosure pertains to a solution including a poly (-olefin) and a reactive organometallic reagent. In a further embodiment, the present disclosure pertains to a solution including an oligomeric hydrocarbon and a reactive organometallic reagent. In an additional embodiment, the present disclosure pertains to a method for creating a solution, where the method includes adding a reactive organometallic reagent to an oligomeric hydrocarbon.

A trisamide compound has the structure of Formula (I) ##STR00001##
in which R.sup.1, R.sup.2, and R.sup.3 are independently selected from the group consisting of alkyl groups. A polymer composition comprises a trisamide compound of Formula (I) and a polyolefin polymer. The polymer compositions containing a trisamide compound of Formula (I) exhibit very low haze levels and minimal extraction of the trisamide compound.

A trisamide compound has the structure of Formula (I) ##STR00001##
in which R.sup.1, R.sup.2, and R.sup.3 are independently selected from the group consisting of alkyl groups. A polymer composition comprises a trisamide compound of Formula (I) and a polyolefin polymer. The polymer compositions containing a trisamide compound of Formula (I) exhibit very low haze levels and minimal extraction of the trisamide compound.

The present disclosure provides, in part, compounds of formula (I), wherein the variables are as defined herein, pharmaceutical compositions comprising the compounds, and methods of using the compounds to treat physiological disorders, such as proliferative disorders, mediated by TEA domain transcription factors.

The present disclosure provides, in part, compounds of formula (I), wherein the variables are as defined herein, pharmaceutical compositions comprising the compounds, and methods of using the compounds to treat physiological disorders, such as proliferative disorders, mediated by TEA domain transcription factors.